Best Conduits and Best Surgeons for the Best Outcome

Myocardial revascularization surgery is still one of the most effective treatment strategies against coronary disease. One of the most important advantages of surgery over angioplasty is the chance to reach complete revascularization. This has proven to improve the survival of patients and to reduce the number of cardiovascular events.

Tasa de stroke post cirugía vs angioplastia coronaria en un análisis de más de 10.000 pacientes

The choice of conduit for the grafts is critical to ensure their patency (ultimately, to ensure complete revascularization for a longer time).

Given the accelerated decay of vein grafts (50% are occluded at 10 years), the internal thoracic artery has become the gold standard to connect the anterior descending artery.

However, the use of arterial grafts from an artery other than the internal thoracic artery is very low. The bilateral internal thoracic artery is used in around 4.9% of cases, and the radial artery is used in 6.5% of cases.


Read also: Do Polymers Play any Role in Drug Eluting Stents.


The lack of adoption of full arterial revascularization is partially due to a lack of solid, unequivocal evidence on its benefit.

While several series and meta-analysis have shown the benefit of arterial revascularization, recent randomized studies have not been able to do so. This means that there is no solid evidence justifying its higher technical difficulty, its higher procedural time, and its potential complications.

This study, published in J Am Coll Cardiol, included an impressive group of 61,310 patients who underwent coronary artery bypass graft surgery with a single arterial graft (n = 49,076; 80%) or multiple arterial grafts (n = 12,234; 20%). Authors used propensity score matching to reduce the differences between groups. At 1 year, there were no differences between strategies, but at 7 years, the rates of mortality, infarction, and new revascularization were significantly lower in the multiple arterial grafts group.

The greatest strength of this study is the huge number of patients enrolled in 42 hospitals and with 246 surgeons, which can paint a realistic picture of daily clinical practice.



Read also: TAVR in Bicuspid Has the Same Results in Surgery at Hospital Level.


The lowest mortality rates in the multiple arterial grafts group were found in the most experienced sites as regards this strategy.

Another important piece of information is that arterial grafts were significantly associated with wound infections.

Conclusion

The rates of mortality and combined events at 1 year were similar between surgery with a single arterial graft and multiple arterial grafts. However, at 7 years, multiple arterial grafts showed clear benefit from all points of view.

Original title: Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.

Reference: Zaza Samadashvili et al. J Am Coll Cardiol 2019;74:1275–85.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...